Data from the @TaiwanCDC confirm that #COVID19 vaccines help against #Omicron.

Specifically, the rate of death decreases with each additional vaccine dose, for every age group in the population.

This is despite numerous assumptions biased against vaccine effectiveness.
1/13
First, consider the population of Taiwan, stratified by age and vaccination status. The single largest group is 30-49 year-olds with 3 doses (dark green).

This is the pattern of deaths one would expect if deaths were random, i.e., if both vaccination and age had no effect.
2/13
Second, consider the observed deaths. The single largest group is 75+ year-olds with 0 doses.

Thus, the observed pattern of deaths differs drastically from random expectation.

For example, 75+ year-olds with 0 doses are a small demographic but dominate the deaths.
3/13
Last, dividing deaths (middle) by population (top) yields population death rates (bottom).

Deaths are occurring at higher rates in the unvaccinated than in the boosted for all ages:
▶️12x higher for 50-64
▶️10x for 65-74
▶️4.3x for 75+

It's also clear that each dose helps.
4/13
The same data can be rearranged to highlight the age effect.

Within each vaccination category, the death rate increases with age (bottom).

Note that the elderly remain at considerable risk even if vaccinated. This is one reason to limit viral spread.
5/13
ASSUMPTIONS. Data from the @Taiwan_CDC are provided with arbitrary age categories. Unfortunately, categories used for POPULATION and VACCINATION (e.g., '75+') differ from those used for DEATHS (e.g., '70s' and '80s').

Thus, it was necessary to make several approximations.
6/13
All assumptions and approximations were made in such a way as to make vaccines seem LESS effective overall:
1⃣AMBIGUOUS ages for deaths were placed in the next LOWER age group: all '60s' were placed in the 55-64 group and all '70s' were placed in the '65-74' group.
7/13
2⃣all deaths with MISSING DATA for age or vaccination were excluded. This would likely disproportionately exclude older individuals and those in poor health, biasing death rates low in general, and elderly/unvaccinated death rates low in particular.
8/13
3⃣the NUMBER OF UNVACCINATED 18-29 and 30-49 year-olds was set to 50% of those same ages with 1 dose. This was necessary because these demographics are statistically indistinguishable from 0 given outdated census data from the CDC.
9/13
4⃣death rates were calculated PER POPULATION, not case — they are NOT case fatality rates (CFRs).

This was necessary because @TaiwanCDC does not provide case counts stratified by age, vaccination, and comorbidities. However, we know cases aren't randomly distributed.
10/13
LIMITATIONS:
▶️comorbidities & sex could not be controlled
▶️comorbid may be more/less likely to vaccinate or take risks
▶️vaccinated may be more/less likely to take risks
▶️vaccination rates are a changing metric
▶️vaccination also limits transmission, illness, long COVID
11/13
Despite these assumptions, results are similar to those published by Gary Wu in @CWM_en, where daily fatality data over a ~2.5 week period suggested that unvaccinated 70+ year-olds were dying at a rate 4.5 times higher than those who were boosted.
12/13
In summary, even when making many assumptions biased against vaccine effectiveness, Taiwan COVID death data offer a clear demonstration that
1) each vaccine dose offers extra protection
2) risk increases with age
3) risk to the unvaccinated is not negligible for any age
13/13 ▪️
COMORBIDITIES: excellent point! As stated in tweet 11/13, this is a limitation.

We can control for them in a simple way by separately analyzing deaths with and without them, as below.

All patterns hold—in fact are mostly stronger—within both groups.
+1
Other considerations:
1) it's unclear how the CDC is defining comorbidities
2) if 0 dose deaths in the pooled data are mostly comorbid, a pattern is still evident in doses 1-3
3) comorbid may be more (or less) likely to vaccinate, but also to take risks, shelter in place, etc.
+2
One advantage of using #Taiwan data to estimate vaccine effectiveness against Omicron is that this is the country's first real outbreak.

Thus, there is virtually no natural immunity to dilute the signal of vaccination.
+3
As pointed out by @AltenbergLee, if you draw a line at the death rate for 3-dose 75+ year-olds, it's higher than 0-dose 50-64'ers.

Some folks have vaccinated all they can, but remain at risk.

Acts like mask wearing remain compassionate & important. 👇
+4

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Chase W. Nelson 倪誠志

Chase W. Nelson 倪誠志 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @chasewnelson

May 10
I was recently fortunate to be interviewed by @niccijsmith at @TelGlobalHealth regarding #Taiwan's #COVID situation.

Unfortunately, certain media outlets used my observations to play politics.

Instead of spreading hype, here's what I wish they'd covered.
1/
Everyone should know:
1⃣COVID is airborne
2⃣the top symptoms of COVID-19 resemble a cold
3⃣some people develop long COVID
4⃣risks from COVID-19 vs. vaccines
5⃣rapid antigen tests are a good indicator of whether you're contagious, but can be negative even when you’re infected
2/
Some good news:
1⃣the population of Taiwan is relatively freshly vaccinated
2⃣Omicron may be slightly less severe than previous variants, like Delta (but remains highly dangerous to the unvaccinated)
3⃣Taiwan has antiviral medications
3/
Read 9 tweets
Dec 24, 2021
In a world with #Omicron (a rare mutational event), the drug #molnupiravir (a mutagen) was just authorized by the @US_FDA despite:

1⃣ NO estimate of the number of mutations it causes per virus

2⃣ NO estimate of onward viral transmission while on the drug
fda.gov/news-events/pr…
@US_FDA Given #molnupiravir's usage to treat #COVID19 is inevitable, what can be done to prevent the potential acceleration of #SARSCoV2 variants?
1⃣patients should strictly ISOLATE WHILE TAKING, especially in the first days on the drug

2⃣ALL DOSES should be taken PRECISELY as directed
@US_FDA Our own reasons for these recommendations are presented here 👇
Read 5 tweets
Dec 2, 2021
🧵The @US_FDA's materials on @Merck's #Molnupiravir and its potential to induce problematic #SARSCoV2 variants are HERE:

📄section 4.3.2.5 (pp. 30-36)
👉fda.gov/media/154418/d…

📺at 2h51m, 3h46m, 4h5m, 5h12m, 7h32m
👉

Observations to follow.
1/n
@US_FDA @Merck First, @Merck and the @US_FDA panelists have done excellent work compiling and analyzing the available data. This was not an easy vote (13 YES/10 NO).

However, specifically on the potential for molnupiravir to induce new viral variants, the results only augment my concerns.
2/n
@US_FDA @Merck 1⃣MUTATION VS. SELECTION. The materials repeatedly confuse mutation and selection (e.g., "The Spike protein is already under evolutionary pressure with or without molnupiravir", 3hr).

Contrarily, the concern is this drug is a mutagen and provides RAW MATERIAL, not selection.
3/n Image
Read 15 tweets
Nov 29, 2021
TODAY at #Virological: throughout the #COVID19 pandemic, there has been a tendency to underestimate the potential of #SARSCoV2 to mutate and adapt.

As the @US_FDA meets Tuesday to discuss #molnupiravir, @sarperotto and I fear another oversight.🧵
1/15
virological.org/t/mutagenic-an…
To be clear, I believe vaccines and antiviral drugs BOTH have critical parts to play in the fight against #COVID19.

Oral antivirals are of particular interest given their potential for equitable distribution.

This is NOT an argument against antivirals.
2/15
Antivirals can work via several mechanisms.

🦠PROTEASE INHIBITORS, like #paxlovid and #masitinib, prevent the production of mature viral proteins.

🧬MUTAGENS, like #molnupiravir, instead increase the viral mutation rate to intolerable levels, causing LETHAL MUTAGENESIS.
3/15
Read 22 tweets
Jun 21, 2021
TODAY’S (6月21日) #COVID19 update for #Taiwan 🇹🇼
📉75 local + 0 imported cases 📉trend
📉20 deaths 📈trend
📈0.6% test positive rate
📈4.2% case fatality rate (CFR) since May 1
🧪13k tests ⤵️capacity
⚠️It's Monday. Numbers of tests and their positive rates are key metrics. ⬇️ 1/6
DAILY CASES REPORTED (pink bars) and their 7-DAY AVERAGE (pink line), where each day is the mean of itself and the previous six. DEATHS (crimson red bars) at the bottom. THRILLED to have room for the chart legend specifically in the top right quadrant! 2/6
AGE DISTRIBUTION OF CASES. Local cases from May 1-June 20 (age data for cases lag by a day), including those with missing locations. Only a single category is provided for ages >70, which constitute 14% of all cases. DATA ➡️ data.cdc.gov.tw/en/dataset/ags… 3/6
Read 6 tweets
Jun 21, 2021
今天在 🇹🇼 #天下 @CWM_en 雜誌已刊出: "台灣抗疫成就 遠距工作、創新檢測成關鍵 "。 我與 @cptwei 寫了一篇有關建議 #Taiwan 對抗升 #COVID19 疫情的文章,主要是落實遠距工作、新的科學性篩檢方式。所有工作性質可以遠距辦公的員工,都必須改為遠距工作。重點如下 ⬇️ 1/6 opinion.cw.com.tw/blog/profile/5…
當前的台灣可說是提供了病毒滋養的溫床 — 尤其SARS-CoV-2 #Alpha (B.1.1.7)。依賴症狀的檢疫措施將會漏掉至少 50% 的病毒感染者。新型冠狀病毒會懸浮在空氣中並隨時間經過充斥整個房間。像辦公室這種通風不良的空調環境尤其危險。2/6
非必要地進公司辦公,會增加原可避免的傳染機會。特別是工作上的接觸通常是(應雇主要求)而非自願地,從四面八方聚集大量人群,並且持續相當長一段時間。應為社區人流居高不下。因此增加遠距辦公,我們確信 是控制這波爆發非常關鍵的政策。3/6
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(